XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Product revenue, net $ 22,934 $ 26,279 $ 45,033 $ 53,934
Cost of sales 6,731 8,986 14,046 18,609
Gross profit 16,203 17,293 30,987 35,325
Operating expenses:        
Selling and marketing 6,576 10,560 13,998 20,662
General and administrative 5,439 8,018 12,395 15,340
Research and development 524 1,710 1,128 2,774
Amortization of intangible assets 1,300 1,198 2,606 2,395
Impairment expense 0 2,600 0 2,600
Loss from contingent consideration 0 75 0 230
Total operating expenses 13,839 24,161 30,127 44,001
Income (loss) from operations 2,364 (6,868) 860 (8,676)
Other expense, net (1,179) (1,228) (1,888) (2,312)
(Loss) gain on derivative warrant liabilities (577) 1,403 (6,484) 3,594
Income (loss) before income tax 608 (6,693) (7,512) (7,394)
Income tax expense 828 0 828 0
Net loss $ (220) $ (6,693) $ (8,340) $ (7,394)
Basic and diluted weighted-average common shares outstanding (in shares) 5,517,670 3,110,304 5,499,951 2,817,979
Basic and diluted net loss per common share (in dollars per share) $ (0.04) $ (2.15) $ (1.52) $ (2.62)